Delivery Order SPE2DB25D3008-SPE2DB25FRCPR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,550.01 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of inflammatory diseases. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a child contract under AmerisourceBergen's larger federal contract vehicle. The award utilized no set-aside designation and was competitively awarded. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,017.54 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a subcutaneous injectable medication used to treat inflammatory conditions. This firm fixed-price contract is non-competitive, meaning it was issued under an existing contract vehicle rather than through open competition. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $9,166.56 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competed delivery order under AmerisourceBergen's existing DLA contract vehicle. The place of performance is listed as the company's corporate office in...
- The Defense Logistics Agency awarded a $5,506.33 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, which is set to be completed by August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $2,265.90 delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 MG/0.8 MLS, a pharmaceutical product used in the treatment of autoimmune conditions. This contract, awarded on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,394.58 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat inflammatory conditions. The contract was awarded on August 19, 2025, with a completion date of August 20, 2025, and employs firm fixed price pricing with no set-aside designation. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $1,556.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat inflammatory conditions. This non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,812.52 to AmerisourceBergen Drug Corp for HUMIRA (Pen) 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside award executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency awarded a $41,926.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supply. This non-competitive delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract under AmerisourceBergen's larger federal pharmaceutical supply vehicle. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating inflammatory conditions. The contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCPRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medical products to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor that supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/17/25 |